NCT03248648View on ClinicalTrials.gov

Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

September 1, 2017

Study Completion Date

December 1, 2017

Conditions
Postoperative Pain
Interventions
DRUG

Neostigmine

patient receive 0.5mg/dose neostigmine +18ml 0.25%bupivacaine in a total volume of 20 ml.

DRUG

ketamine

patient receive 0.5 mg/kg ketamine+18ml 0.25%bupivacaine in a total volume of 20 ml.

Trial Locations (1)

Egypt, 715715

Assiut university hospitals, Asyut

All Listed Sponsors
collaborator

Ghada Mohammed AboelFadl

UNKNOWN

collaborator

Abualauon Elbiblawy

UNKNOWN

lead

Assiut University

OTHER

NCT03248648 - Efficacy of Intra-articular Neostigmine Versus Ketamine for Postoperative Analgesia in Arthroscopic Knee Surgery | Biotech Hunter | Biotech Hunter